Osman Moneer

Dec 11, 2023 | medicalxpress.com | Osman Moneer

Research from the Gupta Lab provides important insights into the extrahepatic bile ducts. These bile ducts outside of the liver are a critical but poorly understood component of the human digestive system.

Dec 8, 2023 | medicine.yale.edu | Osman Moneer

Recent research from the Gupta Lab, led by Serrena Singh and supervised by Vikas Gupta, MD, PhD, assistant professor of medicine (digestive diseases), provides important insights into the extrahepatic bile ducts. These bile ducts outside of the liver are a critical but poorly understood component of the human digestive system.

Nov 30, 2023 | medicalxpress.com | Osman Moneer

A recent study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with HIV and HCV has been increasing. If left untreated, HCV infection can lead to liver damage, cancer, and death. Although HIV requires lifelong therapy, HCV can be cured with a few months of oral medications.

Nov 29, 2023 | medicine.yale.edu | Osman Moneer

A new study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with HIV and HCV has been increasing. If left untreated, HCV infection can lead to liver damage, cancer, and death. Although HIV requires lifelong therapy, HCV can be cured with a few months of oral medications.

Nov 6, 2023 | medicine.yale.edu | Osman Moneer

HIV weakens the immune system over time, leaving people with the virus susceptible to developing malignancies such as Kaposi sarcoma and lymphomas, but also more common cancers as they age. Patients living at this unique intersection of HIV and cancer face complex medical challenges, and traditional cancer care pathways often do not effectively address the specific needs of individuals with HIV.